A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO)

PHASE3CompletedINTERVENTIONAL
Enrollment

239

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Gastric Ulcer
Interventions
DRUG

PN400 (VIMOVO)

Subjects are instructed to take 2 tablets a day, one in the morning and one in the afternoon/evening. The morning tablet should be taken with water, on an empty stomach 30 to 60 minutes before breakfast, or the first meal. The afternoon/evening tablet should be taken with water, on an empty stomach 30 to 60 minutes before dinner. Tablets should be swallowed whole and not broken, crushed or chewed.

DRUG

PN 400 (VIMOVO)

500 mg delayed-release naproxen/20 mg immediate release esomperazole dosed twice daily for 12 months

Trial Locations (1)

27519

POZEN, Chapel Hill

Sponsors

Lead Sponsor

All Listed Sponsors
lead

POZEN

INDUSTRY